PrimeGenX Therapeutics Co., Ltd.（Business Registration Number: 79657826）

• Business Registration Number: 79657826
• Chinese Name: 北京普祺醫藥科技股份有限公司
• English Name: PrimeGenX Therapeutics Co., Ltd.
• Date of Establishment: 2026-01-22
• Category：Medical,Technology,Finance and Technology,Biotechnology and Healthcare (Click to browse Hong Kong Medical,Technology,Finance and Technology,Biotechnology and Healthcare companies)
• Company Category: Registered Non-Hong Kong Company
• Active Status: Live
• 🛒Buy PrimeGenX Therapeutics Co., Ltd. instant paid report(Report results will be returned within 30 minutes after payment)
• 🛒Purchase PrimeGenX Therapeutics Co., Ltd. customized query report by field(Report results will be returned according to customer-customized fields within 24 hours at the fastest)
• Website: PrimeGenX Therapeutics Co., Ltd. Website
• Update On: 2026-01-29 09:30:08
• 🛒Instantly query the Hong Kong company where the target is a director through the person's name, company name and company business registration number (results available within 30 minutes)
• 🛒Purchase PrimeGenX Therapeutics Co., Ltd. Detailed Report (including company background, capital information, key personnel, customs data, information on persons subject to enforcement, company risks, etc.)
• 🛒Purchase PrimeGenX Therapeutics Co., Ltd. Ultimate Beneficial Owner Report
• Source: DATA.GOV.HK

• Company Address: Pay To View
• First Shareholder: Pay To View
• Current Shareholders: Pay To View
• First Director: Pay To View
• Current Director: Pay To View
• First Secretary: Pay To View
• Current Secretary: Pay To View
• Company Issued and Paid-up Share Capital: Pay To View
• Shareholding Ratio of Current Shareholders: Pay To View
• Hong Kong Companies Related to Directors Report!
• The Information of Current Shareholders of Several Hong Kong Companies Report!
• Purchase PrimeGenX Therapeutics Co., Ltd. Brief Company Report!

• Register of Charges: None
• Date of Annual Examination: January 22, 2027 to March 04, 2027. A private company is required to file an annual return within 42 days after the first anniversary of its incorporation. In addition, according to section 622 of the Companies Ordinance, if a company fails to comply with the provision, the company and every responsible person of the company are liable to prosecution and, if convicted, default fines. The maximum penalty is HK$50,000 for each breach and, in the case of a continuing offence, a daily default fine of HK$1,000.
• Name of History:
  2026年1月22日
  PrimeGenX Therapeutics Co., Ltd.
  北京普祺醫藥科技股份有限公司

Due to differences in time or information disclosure format, the information may not be completely consistent with objective facts. It is recommended that you purchase the company report if you need the latest information from the company.

View larger image